article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.

article thumbnail

17th edition of CPHI & PMEC India inaugurated at India Expo Centre, Noida

Express Pharma

With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Unveiling excellence in pharma Day 1 of the event showcased the Pharma Connect Congress, which addressed pivotal themes shaping the pharmaceutical landscape.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CPHI to return to Messe Frankfurt in 2025

Express Pharma

CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.

Dosage 104
article thumbnail

CPHI to return to Milan in 2024

European Pharmaceutical Review

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. This year’s event marks the 20th anniversary of the CPHI Pharma Awards.

Dosage 98
article thumbnail

FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death

Express Pharma

FINEARTS-HF is a randomised, double-blind, placebo-controlled, multicenter, event-driven Phase III trial to assess the efficacy and safety of finerenone on top of standard therapies in patients with a mildly reduced or preserved left ventricular ejection fraction of 40 per cent or greater.

Dosage 104
article thumbnail

Sandoz granted novel biosimilars approval

European Pharmaceutical Review

Keren Haruvi, President Sandoz North America highlighted that denosumab is a medicine that can address primary and secondary bone loss, such as osteoporosis, as well as cancer-related skeletal events. Wyost Similarly, Wyost 120 mg/1.7 mL (70 mg/mL) injection is a human monoclonal antibody designed to bind to the RANKL protein.